{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:27:59Z","timestamp":1792661279111,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.03.054","type":"journal-article","created":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T17:09:18Z","timestamp":1208020158000},"page":"2824-2832","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of \u03b1-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients"],"prefix":"10.1016","volume":"26","author":[{"given":"Redas","family":"Trepiakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Elm","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zcan","family":"Met","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten H.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Berntsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.03.054_bib1","first-page":"769","article-title":"Immunity to methylcholantrene-induced sarcomas","volume":"18","author":"Prehn","year":"1957","journal-title":"J Natl Cancer Inst"},{"issue":"3 (February)","key":"10.1016\/j.vaccine.2008.03.054_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI0214364","article-title":"Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.","volume":"109","author":"Heiser","year":"2002","journal-title":"J Clin Invest"},{"issue":"6 (June)","key":"10.1016\/j.vaccine.2008.03.054_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-003-0375-x","article-title":"Durable complete clinical responses in a phase I\/II trial using an autologous melanoma cell\/dendritic cell vaccine.","volume":"52","author":"O\u2019Rourke","year":"2003","journal-title":"Cancer Immunol Immunother"},{"issue":"4 (August)","key":"10.1016\/j.vaccine.2008.03.054_bib4","article-title":"Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients","volume":"16","author":"Ridolfi","year":"2006","journal-title":"J Transl Med"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2008.03.054_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines.","volume":"117","author":"Gilboa","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2008.03.054_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"issue":"14 (November 1)","key":"10.1016\/j.vaccine.2008.03.054_bib7","first-page":"5091","article-title":"Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients","volume":"9","author":"de Vries","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2008.03.054_bib8","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur J Immunol"},{"issue":"4 (April)","key":"10.1016\/j.vaccine.2008.03.054_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","article-title":"Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG","volume":"17","author":"Schadendorf","year":"2006","journal-title":"Ann Oncol"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2008.03.054_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.cgt.7700961","article-title":"Phase I\/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA","volume":"13","author":"Kyte","year":"2006","journal-title":"Cancer Gene Ther"},{"issue":"147","key":"10.1016\/j.vaccine.2008.03.054_bib11","first-page":"156","article-title":"Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination","volume":"61","author":"Pedersen","year":"2006","journal-title":"Scand J Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.03.054_bib12","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-04-1261","article-title":"alpha-type-I polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity","volume":"64","author":"Maillard","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2008.03.054_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00262-003-0493-5","article-title":"Vaccination with p53 peptide pulsed dendritic cells of patients with advanced breast cancer: report from a phase I study","volume":"53","author":"Svane","year":"2004","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.054_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-007-0293-4","article-title":"Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; application of serum YKL-40 and IL-6 as response biomarkers","volume":"56","author":"Svane","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.054_bib15","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"2006","journal-title":"Eur J Immunol"},{"issue":"Pt 12 (December)","key":"10.1016\/j.vaccine.2008.03.054_bib16","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1107\/S0907444901016249","article-title":"Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1","volume":"57","author":"Josephson","year":"2001","journal-title":"Acta Crystallogr D: Biol Crystallogr"},{"issue":"3 (February 1)","key":"10.1016\/j.vaccine.2008.03.054_bib17","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J Immunol"},{"issue":"47 (November 23)","key":"10.1016\/j.vaccine.2008.03.054_bib18","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"PNAS"},{"issue":"11 (November)","key":"10.1016\/j.vaccine.2008.03.054_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"24 (December 15)","key":"10.1016\/j.vaccine.2008.03.054_bib20","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1158\/0008-5472.CAN-07-2259","article-title":"Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer","volume":"67","author":"Kottke","year":"2007","journal-title":"Cancer Res"},{"issue":"4 (August 15)","key":"10.1016\/j.vaccine.2008.03.054_bib21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1182\/blood-2001-11-0017","article-title":"Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells","volume":"100","author":"Scandella","year":"2002","journal-title":"Blood"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2008.03.054_bib22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"issue":"3 (February 1)","key":"10.1016\/j.vaccine.2008.03.054_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4049\/jimmunol.164.3.1269","article-title":"Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells","volume":"164","author":"Kiertscher","year":"2000","journal-title":"J Immunol"},{"issue":"1 (July 1)","key":"10.1016\/j.vaccine.2008.03.054_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"issue":"7 (April 1)","key":"10.1016\/j.vaccine.2008.03.054_bib25","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.170.7.3488","article-title":"Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis","volume":"170","author":"Peguet-Navarro","year":"2003","journal-title":"J Immunol"},{"issue":"8 (October 20)","key":"10.1016\/j.vaccine.2008.03.054_bib26","first-page":"1463","article-title":"Altered maturation of peripheral blood dendritic cells in patients with breast cancer","volume":"89","author":"Della","year":"2003","journal-title":"Br J Cancer"},{"issue":"2 (July 15)","key":"10.1016\/j.vaccine.2008.03.054_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.1323","article-title":"A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection","volume":"93","author":"Jonuleit","year":"2001","journal-title":"Int J Cancer"},{"issue":"49\/50 (November 30)","key":"10.1016\/j.vaccine.2008.03.054_bib28","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1016\/j.vaccine.2006.07.002","article-title":"Interferon-gamma dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines","volume":"24","author":"Alder","year":"2006","journal-title":"Vaccine"},{"issue":"7 (March)","key":"10.1016\/j.vaccine.2008.03.054_bib29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.molimm.2006.08.020","article-title":"Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells","volume":"44","author":"Velten","year":"2007","journal-title":"Mol Immunol"},{"issue":"2 (July 20)","key":"10.1016\/j.vaccine.2008.03.054_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.188.2.373","article-title":"Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites","volume":"188","author":"Dieu","year":"1998","journal-title":"J Exp Med"},{"issue":"3 (February 1)","key":"10.1016\/j.vaccine.2008.03.054_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.189.3.451","article-title":"Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization","volume":"189","author":"Gunn","year":"1999","journal-title":"J Exp Med"},{"issue":"1 (October 1)","key":"10.1016\/j.vaccine.2008.03.054_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"Forster","year":"1999","journal-title":"Cell"},{"issue":"11 (June 7)","key":"10.1016\/j.vaccine.2008.03.054_bib33","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20031111","article-title":"Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation","volume":"199","author":"Arens","year":"2004","journal-title":"J Exp Med"},{"issue":"5 (September 1)","key":"10.1016\/j.vaccine.2008.03.054_bib34","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.4049\/jimmunol.177.5.2969","article-title":"Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming","volume":"177","author":"Taraban","year":"2006","journal-title":"J Immunol"},{"issue":"3 (March)","key":"10.1016\/j.vaccine.2008.03.054_bib35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.200636824","article-title":"Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells","volume":"37","author":"Schildknecht","year":"2007","journal-title":"Eur J Immunol"},{"issue":"7 (April 1)","key":"10.1016\/j.vaccine.2008.03.054_bib36","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2004-07-2959","article-title":"Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR","volume":"105","author":"Valzasina","year":"2005","journal-title":"Blood"},{"issue":"13 (December 15)","key":"10.1016\/j.vaccine.2008.03.054_bib37","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2007-07-104604","article-title":"Differential costimulation through CD137 (4 1BB) restores proliferation of human virus-specific \u201ceffector memory\u201d (CD28 CD45RAHI) CD8+ T cells","volume":"110","author":"Waller","year":"2007","journal-title":"Blood"},{"issue":"47 (November 23)","key":"10.1016\/j.vaccine.2008.03.054_bib38","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3 (September)","key":"10.1016\/j.vaccine.2008.03.054_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jlb.66.3.375","article-title":"A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells","volume":"66","author":"Colonna","year":"1999","journal-title":"J Leukoc Biol"},{"issue":"3 (June)","key":"10.1016\/j.vaccine.2008.03.054_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coi.2007.04.012","article-title":"PD-1 and its ligands in T-cell immunity","volume":"19","author":"Keir","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"3 (March)","key":"10.1016\/j.vaccine.2008.03.054_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2008.03.054_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gene.2004.02.018","article-title":"Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation","volume":"331","author":"Ju","year":"2004","journal-title":"Gene"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2008.03.054_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.intimp.2004.09.003","article-title":"Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review","volume":"5","author":"Suciu-Foca","year":"2005","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.054_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00281-002-0100-4","article-title":"Immunopathology during coxsackievirus infection","volume":"24","author":"Whitton","year":"2002","journal-title":"Springer Semin Immunopathol"},{"issue":"3 (August 1)","key":"10.1016\/j.vaccine.2008.03.054_bib45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4049\/jimmunol.175.3.1586","article-title":"Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production","volume":"175","author":"Yamazaki","year":"2005","journal-title":"J Immunol"},{"issue":"11 (August)","key":"10.1016\/j.vaccine.2008.03.054_bib46","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1096\/fj.03-1367fje","article-title":"Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells","volume":"18","author":"Sheibanie","year":"2004","journal-title":"FASEB J"},{"issue":"7 (April 1)","key":"10.1016\/j.vaccine.2008.03.054_bib47","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.4049\/jimmunol.166.7.4312","article-title":"Regulatory activity of autocrine IL-10 on dendritic cell functions","volume":"166","author":"Corinti","year":"2001","journal-title":"J Immunol"},{"issue":"12 (June 15)","key":"10.1016\/j.vaccine.2008.03.054_bib48","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.4049\/jimmunol.178.12.7571","article-title":"Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12","volume":"178","author":"Kaiga","year":"2007","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T07:30:33Z","timestamp":1588577433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":48,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X08003897"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}